Cell Factors PDPAs* – The Next Generation in Regenerative Medicine
*Placenta Derived Protein Arrays
- Are you interested in providing for your patients the most advanced treatment modality available in Regenerative Medicine?
- Differentiate yourself and your clinic in the market?
- Add a new and lucrative revenue stream to your practice?
- Be free from the regulatory issues associated with current Regenerative Medicine treatment modalities?
Our Regeneration Formulations Team plus our Cell Factors PDPAs product can help you to achieve these goals!
Cell Factors PDPAs (Placenta Derived Protein Arrays) are an acellular compound (no DNA or biological material) which is classified in the same category as sterile, injectable compounds like compounded vitamins and minerals and as such it does not face the kind of regulatory challenges like stem cells, exosomes etc.
The lab that produces CellFactors is a U.S. – cGMP/FDA certified lab that has developed a process to extract from stem cells all 30,000+ gene expressions in the human genome: cytokines, all growth factors etc.
The source material includes tissue from all 5 key parts of the placenta: Wharton’s Jelly, Amniotic Fluid, the Amnion Membrane, the Chorion Membrane & Umbilical Cord Blood
Patient Testimonial: NFL Prospect: From career ending bone on bone knee injury to to growing new cartilage and recovery
Ben G – Knee Recovery Testimonial
Adam Sewell MD – President of the American Arthritis Foundation interviews an industry expert regarding the potential of PDPAs
Dr. Sewell endorses Cell Factors and uses it extensively in his practice
For more information on Cell Factors PDPAs and to set up a consultation reach out to us:
Rob Lamberton – Chief Science Officer – Regeneration Formulations, LLC
Email: Rob@GetCellFactors.com Phone: 778-227-4952
Cell Factors: Next Generation Regenerative Medicine
Placenta Derived Protein Arrays (PDPAs)
Performance, Safety and Applications Beyond Stem Cells and Exosomes
Patient Testimonial: Dr. Steinberg’s Knee Recovery Journey: Overcoming Knee Pain with Cell Factor Technology
